Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
作者信息
Buchacher Lukas, Richtig Georg, Dernoscheg Marie, Richtig Erika, Koch Lukas
机构信息
Department of Dermatology, Medical University of Graz, Graz, Austria.
Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
出版信息
J Eur Acad Dermatol Venereol. 2023 May;37(5):e605-e607. doi: 10.1111/jdv.18871. Epub 2023 Jan 25.
PMID:36645848
Abstract
摘要
Zotero 插件